3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Neuroendocrine Tumors
2
Urogenital Neoplasms
1
Prostatic Diseases
1
Oligometastatic Prostate Cancer (OMPC)
1
Metastatic Neuroendocrine Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer (mCRPC)
1
Carcinoma, Merkel Cell
1
Carcinoma
1
Advanced Gastroenteropancreatic Neuroendocrine Tumor
1
Interventions
Etoposide
3
fludarabine phosphate
2
fludarabine
2
Cyclophosphamide
2
Carboplatin
2
repotrectinib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
Vorinostat
1
Standard of Care
1
Specimen Handling
1
Respiratory Physiological Phenomena
1
Practice Guidelines as Topic
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
Ifosfamide
1
Cytapheresis
1
Cisplatin
1
Bleomycin
1
Biopsy
1
Automobiles
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Lutetium-177
×
90 days
×
Clear all
No trials found.